Antibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment

Autor: Bagri, Anil, de Assis, Rafael R, Tsai, Cheng-Ting, Simmons, Graham, Mei, Zhen W, Von Goetz, Melissa, Gatmaitan, Michelle, Stone, Mars, Di Germanio, Clara, Martinelli, Rachel, Darst, Orsolya, Rioveros, Jowin, Robinson, Peter V, Ward, Dawn, Ziman, Alyssa, Seftel, David, Khan, Saahir, Busch, Michael P, Felgner, Philip L, Corash, Laurence M

Publikováno v: Transfusion, vol 62, iss 3

BackgroundCOVID-19 convalescent plasma (CCP), from donors recovered from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, is one of the limited therapeutic options currently available for the treatment of critically ill patient

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::c76d137190f02bd0ecc416a2b45bb052
https://escholarship.org/uc/item/93r7m1n4

Role of von Willebrand Factor in COVID-19 Associated Coagulopathy.

Autor: Mei, Zhen W, van Wijk, Xander M R, Pham, Huy P, Marin, Maximo J

Publikováno v: Journal of Applied Laboratory Medicine; Sep2021, Vol. 6 Issue 5, p1305-1315, 11p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Antibody profiles in COVID-19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment.

Autor: Bagri A; Transfusion Medicine Research, Cerus Corporation, Concord, California, USA., de Assis RR; Department of Physiology and Biophysics, School of Medicine, University of California Irvine, Irvine, California, USA., Tsai CT; Enable Biosciences Inc, South San Francisco, California, USA., Simmons G; Scientific Research Programs, Vitalant Research Institute, San Francisco, California, USA., Mei ZW; Wing-Kwai and Alice Lee-Tsing Chung Transfusion Service, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles, California, USA., Von Goetz M; Transfusion Medicine Research, Cerus Corporation, Concord, California, USA., Gatmaitan M; Transfusion Medicine Research, Cerus Corporation, Concord, California, USA., Stone M; Scientific Research Programs, Vitalant Research Institute, San Francisco, California, USA., Di Germanio C; Scientific Research Programs, Vitalant Research Institute, San Francisco, California, USA., Martinelli R; Scientific Research Programs, Vitalant Research Institute, San Francisco, California, USA., Darst O; Scientific Research Programs, Vitalant Research Institute, San Francisco, California, USA., Rioveros J; Wing-Kwai and Alice Lee-Tsing Chung Transfusion Service, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles, California, USA., Robinson PV; Enable Biosciences Inc, South San Francisco, California, USA., Ward D; Wing-Kwai and Alice Lee-Tsing Chung Transfusion Service, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles, California, USA., Ziman A; Wing-Kwai and Alice Lee-Tsing Chung Transfusion Service, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles, California, USA., Seftel D; Enable Biosciences Inc, South San Francisco, California, USA., Khan S; Division of Infectious Diseases, Department of Medicine, University of California Irvine Health, Orange, California, USA., Busch MP; Scientific Research Programs, Vitalant Research Institute, San Francisco, California, USA., Felgner PL; Department of Physiology and Biophysics, School of Medicine, University of California Irvine, Irvine, California, USA., Corash LM; Transfusion Medicine Research, Cerus Corporation, Concord, California, USA.

Publikováno v: Transfusion [Transfusion] 2022 Mar; Vol. 62 (3), pp. 570-583. Date of Electronic Publication: 2022 Feb 12.